Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             126 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acinetobacter/stenotrophomonas 1999
5 S3 p. 367-371
5 p.
artikel
2 Animal models 1999
5 S3 p. 339-342
4 p.
artikel
3 Bacteremia/endocarditis 1999
5 S3 p. 371-378
8 p.
artikel
4 Beta-lactamase/ESBL 1999
5 S3 p. 106-112
7 p.
artikel
5 Carbapenems in serious infections: maximizing the power, minimizing resistance 1999
5 S3 p. 12-14
3 p.
artikel
6 Challenges in the treatment of febrile neutropenia 1999
5 S3 p. 47-48
2 p.
artikel
7 Changing treatment perceptions in community-acquired lower respiratory tract infections 1999
5 S3 p. 4-5
2 p.
artikel
8 Chlamydia pneumoniae—a pathogen involved in many diseases 1999
5 S3 p. 11-
1 p.
artikel
9 Chronic hepatitis: new approaches in diagnosis and treatment 1999
5 S3 p. 41-42
2 p.
artikel
10 Clinical impact of new diagnostic methods in microbiology 1999
5 S3 p. 18-19
2 p.
artikel
11 Clinical implications of antibiotics resistance in developing countries 1999
5 S3 p. 27-
1 p.
artikel
12 Clinical microbiology: a pivotal interface in patient and health care management 1999
5 S3 p. 7-8
2 p.
artikel
13 Community acquired pneumonia 1999
5 S3 p. 151-157
7 p.
artikel
14 Community-acquired pneumonia (CAP) in the next century 1999
5 S3 p. 29-
1 p.
artikel
15 Current aspects in anaerobic infections 1999
5 S3 p. 36-37
2 p.
artikel
16 Disinfection and surgical infections 1999
5 S3 p. 387-389
3 p.
artikel
17 Emerging pediatric infectious diseases 1999
5 S3 p. 38-39
2 p.
artikel
18 Endocarditis and Sepsis 1999
5 S3 p. 56-58
3 p.
artikel
19 Enteric pathogens 1999
5 S3 p. 265-272
8 p.
artikel
20 Epidemiology/surveillance and outbreaks 1999
5 S3 p. 63-64
2 p.
artikel
21 Eradication of infectious diseases—past and future 1999
5 S3 p. 34-35
2 p.
artikel
22 Exotoxins 1999
5 S3 p. 24-26
3 p.
artikel
23 Fluoroquinolones I 1999
5 S3 p. 138-148
11 p.
artikel
24 Fluoroquinolones II 1999
5 S3 p. 296-304
9 p.
artikel
25 Fungal diseases: diagnosis, virulence factors, antifungal agents 1999
5 S3 p. 64-66
3 p.
artikel
26 Fungal infections I 1999
5 S3 p. 278-286
9 p.
artikel
27 Fungal infections II 1999
5 S3 p. 396-404
9 p.
artikel
28 Genome analysis and infectious diseases 1999
5 S3 p. 10-
1 p.
artikel
29 Glycopeptide resistance 1999
5 S3 p. 31-
1 p.
artikel
30 Hantavirus—pathogenesis diagnosis, clinical approach 1999
5 S3 p. 45-46
2 p.
artikel
31 Health care issues/public health 1999
5 S3 p. 85-91
7 p.
artikel
32 Helicobacter pylori 1999
5 S3 p. 42-
1 p.
artikel
33 Helicobacter pylori 1999
5 S3 p. 258-265
8 p.
artikel
34 Hepatitis 1999
5 S3 p. 218-227
10 p.
artikel
35 HIV/AIDS 1999
5 S3 p. 53-56
4 p.
artikel
36 HIV-epidemiology, opportunistic infections I 1999
5 S3 p. 157-163
7 p.
artikel
37 HIV-epidemiology, opportunistic infections II 1999
5 S3 p. 342-348
7 p.
artikel
38 HIV-virology and treatment 1999
5 S3 p. 227-235
9 p.
artikel
39 Hospital-acquired bloodstream infections 1999
5 S3 p. 32-
1 p.
artikel
40 Immune reconstitution in HIV disease 1999
5 S3 p. 15-
1 p.
artikel
41 Immunocompromised host 1999
5 S3 p. 353-359
7 p.
artikel
42 Immunology, host defences, vaccination I 1999
5 S3 p. 124-130
7 p.
artikel
43 Immunology, host defences, vaccination II 1999
5 S3 p. 242-248
7 p.
artikel
44 Immunology, host defences, vaccination III 1999
5 S3 p. 326-332
7 p.
artikel
45 Immunotherapy in infectious disease—novel treatment concepts 1999
5 S3 p. 30-
1 p.
artikel
46 Increasing resistance in Gram-positive pathogens 1999
5 S3 p. 3-4
2 p.
artikel
47 Infections and cytokines 1999
5 S3 p. 20-21
2 p.
artikel
48 Infections by Gram-positive bacteria 1999
5 S3 p. 323-326
4 p.
artikel
49 Infections by non-tuberculous mycobacteria 1999
5 S3 p. 50-51
2 p.
artikel
50 Infections in the immunocompromised non-neutropenic patient 1999
5 S3 p. 49-50
2 p.
artikel
51 Infectious disease in the 21st century 1999
5 S3 p. 46-
1 p.
artikel
52 Infectious disease problems in Central and Eastern Europe 1999
5 S3 p. 16-18
3 p.
artikel
53 Inflammatory host responses 1999
5 S3 p. 66-69
4 p.
artikel
54 Intensive care unit 1999
5 S3 p. 360-364
5 p.
artikel
55 Intestinal protozoa and echinococcosis 1999
5 S3 p. 9-10
2 p.
artikel
56 Laboratory diagnosis: Automation I 1999
5 S3 p. 91-95
5 p.
artikel
57 Laboratory diagnosis: Automation II 1999
5 S3 p. 304-308
5 p.
artikel
58 Lower respiratory tract infection 1999
5 S3 p. 80-83
4 p.
artikel
59 Lyme disease 1999
5 S3 p. 255-258
4 p.
artikel
60 Meningitis 1999
5 S3 p. 248-252
5 p.
artikel
61 Methicillin-resistant staphylococci 1999
5 S3 p. 113-120
8 p.
artikel
62 Methicillin-resistant Staphylococcus aureus (MRSA)/Vancomycin-resistant enterococci (VRE) 1999
5 S3 p. 72-75
4 p.
artikel
63 Miscellaneous 1999
5 S3 p. 404-410
7 p.
artikel
64 Molecular diagnostic methods 1999
5 S3 p. 69-72
4 p.
artikel
65 Molecular methods for the diagnosis of infectious diseases 1999
5 S3 p. 21-22
2 p.
artikel
66 Molecular methods in the diagnostic laboratory: when to start and where to stop 1999
5 S3 p. 40-41
2 p.
artikel
67 Molecular typing 1999
5 S3 p. 193-199
7 p.
artikel
68 Mycobacteria 1999
5 S3 p. 61-63
3 p.
artikel
69 Mycobacterial diseases 1999
5 S3 p. 26-27
2 p.
artikel
70 Mycobacteria-Tbc I 1999
5 S3 p. 95-101
7 p.
artikel
71 Mycobacteria-Tbc II 1999
5 S3 p. 199-205
7 p.
artikel
72 Neonatal infections 1999
5 S3 p. 168-171
4 p.
artikel
73 New advances in the diagnosis and treatment of fungal infections 1999
5 S3 p. 5-7
3 p.
artikel
74 New aspects of cystic fibrosis, lung infection and inflammation 1999
5 S3 p. 48-
1 p.
artikel
75 New developments in treatment of respiratory tract infections 1999
5 S3 p. 39-40
2 p.
artikel
76 New drugs 1999
5 S3 p. 130-138
9 p.
artikel
77 New insights into sepsis and septic shock 1999
5 S3 p. 3-
1 p.
artikel
78 New insights into the pathogenesis and therapy of sepsis 1999
5 S3 p. 14-15
2 p.
artikel
79 New opportunities to improve outcomes in community RTIs 1999
5 S3 p. 44-45
2 p.
artikel
80 Next generation quinolones for a new therapeutic millennium 1999
5 S3 p. 23-24
2 p.
artikel
81 Nosocomial pneumonia 1999
5 S3 p. 364-367
4 p.
artikel
82 Outbreaks 1999
5 S3 p. 389-393
5 p.
artikel
83 Parasitic diseases 1999
5 S3 p. 171-175
5 p.
artikel
84 Pathogenesis 1999
5 S3 p. 332-339
8 p.
artikel
85 Pathogenesis and prevention of polymer-associated staphylococcal infections 1999
5 S3 p. 18-
1 p.
artikel
86 Pediatric infections including vaccination I 1999
5 S3 p. 163-168
6 p.
artikel
87 Pediatric infections including vaccination II 1999
5 S3 p. 348-353
6 p.
artikel
88 Pharmacoeconomics in infectious diseases 1999
5 S3 p. 50-
1 p.
artikel
89 Pharmacokinetics/pharmacodynamics 1999
5 S3 p. 289-295
7 p.
artikel
90 Prevention of infections in immunocompromised patients 1999
5 S3 p. 22-23
2 p.
artikel
91 Progress in meningitis 1999
5 S3 p. 22-
1 p.
artikel
92 Progress in vaccination 1999
5 S3 p. 43-44
2 p.
artikel
93 Quality aspects in clinical microbiology 1999
5 S3 p. 8-9
2 p.
artikel
94 Rare diseases 1999
5 S3 p. 180-185
6 p.
artikel
95 Recent developments in cardiovascular infections 1999
5 S3 p. 35-36
2 p.
artikel
96 Resistance—epidemiology and mechanism 1999
5 S3 p. 75-77
3 p.
artikel
97 Resistance/epidemiology I 1999
5 S3 p. 236-242
7 p.
artikel
98 Resistance/epidemiology II 1999
5 S3 p. 309-315
7 p.
artikel
99 Resistance grampositive bacteria 1999
5 S3 p. 315-323
9 p.
artikel
100 Resistance mechanisms 1999
5 S3 p. 101-106
6 p.
artikel
101 Resistant bacteria—their evolution and pharmacodynamic response to antimicrobials 1999
5 S3 p. 22-
1 p.
artikel
102 Respiratory infections: strategies for a resistance environment 1999
5 S3 p. 19-20
2 p.
artikel
103 Respiratory tract infections 1999
5 S3 p. 272-278
7 p.
artikel
104 Serodiagnosis 1999
5 S3 p. 308-309
2 p.
artikel
105 Severe infections/osteomyelitis 1999
5 S3 p. 378-380
3 p.
artikel
106 Sexually-transmitted diseases (STD) and chlamydial diagnostics 1999
5 S3 p. 185-193
9 p.
artikel
107 Short course antibiotic therapy with macrolides 1999
5 S3 p. 27-28
2 p.
artikel
108 Solid organ transplants 1999
5 S3 p. 286-289
4 p.
artikel
109 Surgical infections and burns 1999
5 S3 p. 384-387
4 p.
artikel
110 Surveillance 1999
5 S3 p. 393-396
4 p.
artikel
111 Surveillance of nosocomial infections in Europe: which methodologies? 1999
5 S3 p. 12-
1 p.
artikel
112 Tb Meningitis/extrapulmonary Tb 1999
5 S3 p. 252-255
4 p.
artikel
113 The role of chemokines and chemokine receptors in the pathogenicity of HIV 1999
5 S3 p. 3-
1 p.
artikel
114 Thinking like bacteria—the modern approach to overcome resistance in Gram-negative bacteria 1999
5 S3 p. 15-16
2 p.
artikel
115 Tolerability/toxicity 1999
5 S3 p. 148-151
4 p.
artikel
116 Towards an integrated molocular epidemiology of infectious diseases: epidemicity, virulence and host susceptibility markers 1999
5 S3 p. 32-33
2 p.
artikel
117 Toxicity of antimicrobial agents: relevance of preclinical data for the clinician 1999
5 S3 p. 16-
1 p.
artikel
118 Toxoplasmosis and its control 1999
5 S3 p. 43-
1 p.
artikel
119 Tropical and parasitic diseases 1999
5 S3 p. 58-60
3 p.
artikel
120 Urinary tract infections 1999
5 S3 p. 175-180
6 p.
artikel
121 Use of indicators for good infection control practice 1999
5 S3 p. 37-38
2 p.
artikel
122 Vancomycin-resistant enterococci 1999
5 S3 p. 120-124
5 p.
artikel
123 Vascular infections (Bartonella/Chlamydia) 1999
5 S3 p. 380-383
4 p.
artikel
124 Viral diagnostics 1999
5 S3 p. 205-210
6 p.
artikel
125 Viral diseases 1999
5 S3 p. 210-218
9 p.
artikel
126 Viral infections (except HIV) 1999
5 S3 p. 77-80
4 p.
artikel
                             126 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland